Senior Director, Scientific Affairs- Investors

  • Work with a talented, cross functional team to develop a compelling and balanced narrative on Pfizer's innovative Research and Development portfolio and efforts for the investor community
  • Provide senior-level scientific, strategic and operational support to Pfizer's Chief Scientific Officer (CSO) and President of Worldwide Research, Development and Medical ( WRDM) and to the Vice President of WRDM Operationsrelated to effective creation and communication of the scientific narrative to the investor community related to COVID-19 programs, mRNA and broader R&D priority areas and programs
  • Monitor WRDM strategy and performance across a broad spectrum of measures and assess peer strategy/performance to help inform the strategic narrative to the investor community
  • Coordinate rapid, thoughtful responses to content-related requests of the Pfizer CSO/ President of WRDM related to the investor community
  • Ensure Pfizer's CSO/ President of WRDM is properly briefed and well prepared at all times for key meetings and presentations related to the investor community

  • Leverage knowledge of science & business to develop presentations for Pfizer's CSO/ President of WRDM to the investor community including at Pfizer Quarterly Corporate Performance meetings.
  • Conduct rapid analyses related to the narrative for the investor community for Pfizer's CSO/ President of WRDM, as requested, e.g., quick portfolio/pipeline analyses, benchmarking summaries, summarizing reports for briefings
  • Ensure creation of compelling scientific narrative to the investor community on COVID-19 programs, mRNA and broader R& D priority areas and programs in collaboration with Investor Relations (IR) and Communications team
  • Lead the development of Pfizer's CSO/ President of WRDM's presentation, Q&A and talking points for Pfizer Quarterly Corporate Performance meetings (in partnership with the IR and Communications teams)
  • Support addressing requests (in collaboration with Investor Relations) for information, analyses, actions and decisions from the CEO, Pfizer's executive leadership team (ELT) and other key stakeholders related the investor community
  • Partner closely with key scientific leaders at Pfizer such as the CSOs for various therapeutic areas (TA) to develop a compelling narrative within and across TAs for the investor community
  • Proactively create a watchlist of key programs and R&D themes to highlight to the investor community as well as a plan for when and how to communicate them (in partnership with the IR and Communications teams)
  • Manage an efficient process to gather scientific information and create a compelling narrative for the investor community
  • Periodically support Pfizer's CSO/ President of WRDM monthly 1:1's with the CEO by preparing discussion and background materials related to the investor community
  • Attend key external conferences and events to gauge key trends and peer strategy and performance in order to inform Pfizer's scientific narrative to the investor community


Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
  • PhD in Biology, Chemistry, or other scientific discipline, or equivalent required
  • 10+ years of relevant BioPharma experience including preferably 5+ years in R&D
  • 5+ years experience in management consulting, communications or equity analyst experience required
  • 3+ years experience in crafting scientific presentations for executive audiences required
  • Highly skilled at Microsoft Office applications, especially PowerPoint and Excel
  • Ability to multitask and deal with a large volume of requests / deliverables on a regular basis
  • Ability to quickly/effectively prioritize and balance competing tasks in real-time
  • Bringing a strong and advanced scientific mindset and knowledge to work on scientific initiatives and presentations for the Pfizer CSO/ President of WRDM
  • Willingness to take on and deliver against important tactical / operational tasks on a day-to-day basis
  • Ability to work independently and own deliverables from end to end and at the same time, being able to accept/respond to specific guidance from manager to support near-term or urgent tasks
  • Ability to work collaboratively with key stakeholders
  • Sound business judgment and business acumen to ensure that the thinking and recommendations are grounded in reality and in the best interests of the business
  • Ability to develop strong interpersonal relationships with and influence key WRDM leaders (WRDM-LT and LT-1) and earn their trust - to facilitate easy communication and allow quick access to information needed for the President of WRDM
  • Ability to develop a broad, big picture understanding across WRDM units/lines so that this can be appropriately reflected in the Pfizer CSO/WRDM President's communications, presentations, briefings, etc.
  • Having a strong presence and interpersonal skills to operate/interact effectively with key Executive-level audiences when needed (e.g., ELT, BOD, CEO's office, Senior external partners, etc.)
  • Individual contributor with ability to work effectively in a matrix environment


Eligible for Relocation Package

Eligible for Employee Referral Bonus

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Research and Development